Clinical Characteristics of Anti-Glutamic Acid Decarboxylase Antibody-Positive Fulminant Type 1 Diabetes

Endocrine Journal - Japan
doi 10.1507/endocrj.ej18-0417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Endocrine Society

Related search

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan

PLoS ONE
Multidisciplinary
2016English

A Case of Fulminant Type 1 Diabetes With Transiently Positive Anti-Gad Antibodies

Endocrine Journal
EndocrinologyMetabolismDiabetes
2003English

Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-Epileptic Drugs

Frontiers in Neurology
Neurology
2018English

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

Detection of Autoantibodies Against Reactive Oxygen Species Modified Glutamic Acid Decarboxylase-65 in Type 1 Diabetes Associated Complications

BMC Immunology
Immunology
2011English

Cerebellar Ataxia Associated With Glutamic Acid Decarboxylase Autoantibody (Anti GAD)

Scholars Journal of Medical Case Reports
2020English

Persisting Antibodies to Glutamic Acid Decarboxylase in Type 1 (Insulin-Dependent) Diabetes Mellitus Are Not Associated With Neuropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1993English

The Role of Anti-Glutamic Acid Decarboxylase Autoantibodies in Mood Disorders

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy